Effect of CPAP on QT interval dispersion in obstructive sleep apnea patients without hypertension

Sleep Medicine

Volumn 8, Issue 5, 2007, Pages 478-483

  Dursunoglu, Dursun ^a   Dursunoglu, Nese ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

CPAP therapy; Obstructive sleep apnea; QT interval dispersion

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; HYPERTENSION; MALE; PATIENT COMPLIANCE; PATIENT SELECTION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; QT PROLONGATION; SLEEP APNEA SYNDROME;

ADULT; BODY MASS INDEX; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; HYPERTENSION; LONG QT SYNDROME; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 34250870095     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.08.002     Document Type: Article

References (45)

1. Perkiomaki J., Koistinen M.J., Yli-Mayry S., and Huikuri H. Dispersion of the QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 26 (1995) 174-179
2. Barr C.S., Naas A., Freeman M., Lang C.C., and Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343 (1994) 327-329
3. Sahu P., Lim P.O., Rana P.S., and Struthers A.D. QT dispersion in medicine: electrophysiological holy grail or fool's gold?. Q J Med 93 7 (2000) 425-431
4. Surawicz B. Will QT dispersion play a role in clinical decision-making? (Editorial; comment). J Cardiovasc Electrophysiol 7 (1996) 777-784
5. Statters D.J., Malik M., Ward D.E., and Camm A.J. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 5 (1994) 672-685
6. Guilleminault C., Connoly S., and Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52 (1983) 490-494
7. Dursunoglu D., Dursunoglu N., Evrengül H., et al. QT interval dispersion in obstructive sleep apnea syndrome patients without hypertension. Eur Respir J 25 (2005) 677-681
8. Dursunoglu N, Dursunoglu D, Özkurt S, Tanriverdi H, Evrengül H, Kiter G. Severe sleep apnea syndrome diagnosed with acute myocardial infarction. Asian Cardiovasc Thorac Ann 2006; 14: in press.
9. Dursunoglu D., Dursunoglu N., Evrengül H., et al. Impact of obstructive sleep apnea on left ventricular mass and global function. Eur Respir J. 26 (2005) 283-288
10. Dursunoglu N, Dursunoglu D, Ki{dotless}li{dotless}ç M. Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index respiration. 2005; 72: 278-84.
11. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
12. Dursunoglu N., and Dursunoglu D. Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis. Tuberk Toraks. 53 3 (2005) 299-306
13. Dursunoglu N., and Dursunoglu D. The effects of obstructive sleep apnea hypopnea syndrome on cardiovascular system. Anadolu Kardiyol Derg 5 (2005) 41-45
14. Peker Y., Hedner J., Norum J., Kraiczi H., and Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166 (2002) 159-165
15. Naughton M.T. The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment. Curr Cardiol Rep. 7 3 (2005) 211-215
16. Sullivan C.E., Issa F.G., Berthon-Jones M., and Eves L. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1 (1981) 862-865
17. Dursunoglu N., Dursunoglu D., Ozkurt S., Gur S., Ozalp G., and Evyapan F. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res. 7 1 (2006) 22 Epub ahead of print
18. Dursunoglu N., Dursunoglu D., Çuhadaroǧlu C., and Ki{dotless}li{dotless}çaslan Z. Acute effects of automated CPAP on blood pressure in the patients with sleep apnea and hypertension. Respiration 72 (2005) 150-155
19. Dursunoglu N, Dursunoglu D, Ozkurt S, et al. Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnea. Sleep Med 2006, in press.
20. Ryan C.M., Usui K., Floras J.S., and Bradlet T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnea. Thorax 60 9 (2005) 781-785
21. Simantirakis E.N., Schiza S.I., Marketou M.E., et al. Severe bradyarrhythmias in patients with sleep apnea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 25 12 (2004) 1070-1076
22. Roche F., Barthelemy J.C., Garet M., Duverney D., Pichot V., and Sforza E. Continuous positive airway pressure treatment improves the QT rate dependence adaptation of obstructive sleep apnea patients. Pacing Clin Electrophysiol 28 (2005) 819-825
23. Yamashita J., Nomura M., Uehara K., et al. Influence of sleep apnea on autonomic nervous activity and QT dispersion in patients with essential hypertension and old myocardial infarction. J Electrocardiol 37 (2004) 31-40
24. Johns M.W. A new method for measuring daytime sleepiness. Sleep 14 (1991) 540-545
25. Indications for Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997;20:406-22.
26. Dingli K., Coleman E.L., Vennelle M., et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J 21 (2003) 253-259
27. American Sleep Disorders Association. The Atlas Task Force:. Bonnet M., Carley D., Carskadom M., et al. EEG arousals: scoring rules and examples. Sleep 15 (1994) 173-174
28. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
29. Perkiomaki J., Koistinen M.J., Yli-Mayry S., and Huikuri H. Dispersion of the QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol. 26 (1995) 174-179
30. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart 7 (1920) 353-370
31. Barr C.S., Naas A., Freeman M., Lang C.C., and Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343 (1994) 327-329
32. Linker N.J., Colonna P., Kekwick C.A., Till J., Camm A.J., and Ward D.E. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69 (1992) 634-638
33. Buja G., Miorelli M., Turrini P., Melacini P., and Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 72 (1993) 973-976
34. Zabel M., Portnoy S., and Franz M.R. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol. 25 (1995) 746-752
35. Kuo C.-S., Munakata K., Reddy C.P., and Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67 (1983) 1356-1367
36. Glancy J.M., Weston P.J., Bhullar H.K., Garrat C.J., Woods K.L., and de Bono D.P. Reproducibility and automatic measurement of QT dispersion. Eur Heart J 17 (1996) 1035-1039
37. Day C.P., McComb M., Matthews J., and Campbell R.W. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 12 (1991) 423-427
38. Valkama J.O., Huikuri H.V., Koistinen M.J., Yli-Mayry S., Airaksinen K.E.J., and Myerburg R.J. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 25 (1995) 437-443
39. Huikuri H.V., Valkama J.O., Airaksinen K.E.J., et al. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation 87 (1993) 1220-1228
40. Nakamura T., Chin K., Hosokawa R., et al. Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest 125 (2004) 2107-2114
41. Arabi Y., Morgan B.J., Goodman B., Puleo D.S., Xie A., and Skatrud J.B. Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 87 (1999) 689-698
42. Dimsdale J.E., Loredo J.S., and Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 35 (2000) 144-147
43. Faccenda J.F., Mackay T.W., Boon N.A., et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 2 (2002) 344-348
44. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 1 (2003) 68-73
45. Doherty L.S., Kiely J.L., Swan V., and McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127 6 (2005) 2076-2084